Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Preventing Relapse and Recurrence of Depression:A Brief Review of Therapeutic Options

Thase, Michael E. · 2006 · CNS Spectrums

Abstract

Depression is increasingly recognized as a highly recurrent and potentially chronic illness that imposes a substantial burden on individuals, families, and society. Evidence indicates that the risks of depressive recurrence, treatment resistance, and chronicity increase as the illness becomes more highly recurrent. Up to 1 year of continuation phase therapy is now recommended for virtually all depressed patients who respond to antidepressants, with a longer course of maintenance phase pharmacotherapy recommended for those who have experienced multiple episodes. Antidepressants, when effective during the acute phase of therapy, reduce the risk of depressive relapse (continuation phase) and recurrence (maintenance phase) by at least 50%. Longer-term antidepressant pharmacotherapy is most effective when the full dose of medication effective during acute-phase treatment is continued. As combined treatment with antidepressants and psychotherapy may improve shorter-term outcomes for patients with more severe recurrent depression, ongoing combined therapy may be indicated, especially for patients at particularly high risk. Approximately 5% to 10% of patients maintained on antidepressants relapse yearly, leading some to implicate tachyphylaxis. However, before attributing relapse or recurrence to diminished responsiveness to antidepressant medication at the neurochemical level, clinicians should ensure that the patient has been adherent to therapy as prescribed and consider other explanations.

Overview

Integrity signals

Registry

Crossref · 10.1017/s1092852900015212

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 59 references

Research works printed but not linked: 6

  1. Paykel, 2006, Int J Neuropsychopharmacol, 1
  2. Quitkin, 1993, Br J Psychiatry Suppl, 30
  3. 1994, Diagnostic and Statistical Manual of Mental Disorders
  4. 1990, Diagnostic and Statistical Manual of Mental Disorders
  5. 2000, Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatrie Association, Am J Psychiatry, 157, 1
  6. Thase, 2000, Drug Treatment Issues in Depression, 35

Cited by

See all 93

Metadata

Authors
Thase, M. E.
Affiliations
University of Pittsburgh Medical Center (US)
Corresponding author
Thase, Michael E.
Venue
CNS Spectrums
Published
2006-12
Volume
11
Issue
S15
Pages
12-21
ISSN
  • 1092-8529 (ISSN-L)
  • 2165-6509
OpenAlex
W2279194165
Cited by
93
References
59
Citations by year
2026: 4 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 7 · 2019: 1 · 2018: 4 · 2017: 5 · 2016: 11 · 2015: 8 · 2014: 4 · 2013: 3 · 2012: 5
FWCI
0.59
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Spectrums (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
recurrent depression, depression relapse, treatment-resistant depression, chronic depression, combined psychotherapy and pharmacotherapy, tachyphylaxis, antidepressant adherence, relapse prevention
MeSH terms
Antidepressive Agents, Major Depressive Disorder, Humans, Placebos, Psychotherapy, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Preventing Relapse and Recurrence of Depression:A Brief Review of Therapeutic Options. https://app.cochat.ai/papers/10.1017/s1092852900015212
The paper
Thase, M. E. (2006). Preventing Relapse and Recurrence of Depression:A Brief Review of Therapeutic Options. CNS Spectrums. https://doi.org/10.1017/s1092852900015212

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.